Amylin Pharmaceuticals Inc. (AMLN)

[surf1944]

8:02AM Amylin Pharma and Takeda voluntarily suspend clinical activities in obesity trial (AMLN) 11.03 : Co and Takeda Pharmaceutical announced that they have suspended clinical activities in an ongoing Phase 2 study examining the safety and effectiveness of the investigational combination therapy pramlintide/metreleptin for the treatment of obesity. The clinical study was voluntarily halted to investigate a new antibody-related laboratory finding with metreleptin treatment in two patients who participated in a previously completed clinical study of obesity.